Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     Pharmaceuticals    

Global Drug formulations Market Research Report

PRODUCT TITLE PUBLISHED
Global Conjugate Vaccines Market Global Conjugate Vaccines Market
The global conjugate animal vaccine market is mainly driven by the growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $201.1 million in 2013 and is expected to reach $305.2 million by 2018 at a CAGR of 8.7% during the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Global Recombinant Vaccines Market Global Recombinant Vaccines Market
The Global Recombinant Animal Vaccine Market is mainly driven by growing prevalence of Animal Diseases and increasing incidences of Zoonotic diseases in humans. It was pegged at $368.9 million in 2013 and expected to be $550.8 million by 2018 at a CAGR of 8.3%. Recombinant Animal Vaccine Market analyzes the market by 6 Products such as Aquaculture, Companion animal vaccines, Equine, Livestock, Porcine, and Poultry. The prominent players in the Market are Sanofi Aventis, Merck, Pfizer, Bayer, and Virbac.
Upcoming
Global Dna Vaccines Market Global Dna Vaccines Market
The global DNA animal vaccine market is mainly driven by growing prevalence of animal diseases and increasing incidences of zoonotic diseases in humans. It was valued at $142.5 million in 2013 and is expected to reach $232.4 million by 2018, at a CAGR of 10.3% for the forecast period. The report analyzes the market by six segments/products: aquaculture, companion animal vaccines, equine, livestock, porcine, and poultry. The prominent players in the market are Sanofi-Aventis, Merck, Pfizer, Inc., Bayer AG, and Virbac.
Upcoming
Animal Vaccines Animal Vaccines
Animal Vaccines and Bacterial vaccines, Viral vaccines,
Upcoming
Synthetic Vaccines Synthetic Vaccines
Synthetic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
Dentritic Vaccines Dentritic Vaccines
Dentritic Vaccines and Live Attenuated Vaccines (LAV),
Upcoming
X-Ray Contrast Media X-Ray Contrast Media
X-Ray Contrast Media and Magnetic resonance imaging contrast media,
Upcoming
Barium-based contrast media Barium-based contrast media
Barium-based contrast media and Iodinated contrast media and
Upcoming
Iodinated contrast media Iodinated contrast media
Iodinated contrast media and Barium-based contrast media and
Upcoming
Gadolinium-based contrast media Gadolinium-based contrast media
Gadolinium-based contrast media and Barium-based contrast media and
Upcoming
Acute myeloid leukemia (AML) Acute myeloid leukemia (AML)
Acute myeloid leukemia (AML) and its peer markets - Burkitt lymphoma,
Upcoming
Acute lymphoblastic leukemia (ALL) Acute lymphoblastic leukemia (ALL)
Acute lymphoblastic leukemia (ALL) and its peer markets - T-cell Lymphoma,
Upcoming
Chronic myeloid leukemia (CML) Chronic myeloid leukemia (CML)
Chronic myeloid leukemia (CML) and its peer markets - Hodgkin lymphoma,
Upcoming
Chronic lymphocytic leukemia (CLL) Chronic lymphocytic leukemia (CLL)
Chronic lymphocytic leukemia (CLL) and its peer markets - T-cell Lymphoma,
Upcoming
Hodgkin lymphoma Hodgkin lymphoma
Hodgkin lymphoma and its peer markets - Burkitt lymphoma,
Upcoming
Hairy-cell leukemia Hairy-cell leukemia
Hairy-cell leukemia and its peer markets - Chronic lymphocytic leukemia (CLL),
Upcoming
Burkitt lymphoma Burkitt lymphoma
Burkitt lymphoma and its peer markets - Chronic lymphocytic leukemia (CLL),
Upcoming
Adult T-cell leukemia Adult T-cell leukemia
Adult T-cell leukemia and its peer markets - Hairy-cell leukemia,
Upcoming
Multiple myeloma Multiple myeloma
Multiple myeloma and its peer markets - Hairy-cell leukemia,
Upcoming
Lymphoplasmacytic lymphoma Lymphoplasmacytic lymphoma
Lymphoplasmacytic lymphoma and its peer markets - Chronic myeloid leukemia (CML),
Upcoming
693 reports | Show
Connect With Us
US/CAN : +1-888-502-0539